Back to touchmedicalmedia.com

Delivering medical education for a global audience delivered by expert faculty.

touchIME
Read Time: 2 mins

World Cancer Day 2022 – “Closing the Care Gap”

Published Online: February 24th 2022
Article:

World Cancer Day takes place on 4 February 2022. This initiative unites communities worldwide to raise awareness and promote education about cancer, prompting governments to take action against the disease. This year’s theme is “closing the care gap”, which highlights the fact that half of the world’s population are unable to access essential health services. Health inequities (as opposed to inequalities, which refers to the uneven distribution of resources) can result from disparities in income and education, geographical location, and from discrimination based on ethnicity, race, gender, sexual orientation, age, disability and lifestyle. Many equity gaps exist around the world, even in high-income countries. However, a number of recent initiatives offer hope to vulnerable individuals. Innovative ideas, such as new partnerships for delivering better screening systems and the use of digital technologies, can help to close the equity gap.

 

Our Editor-in-Chief, Axel Merseburger, said, “I would encourage further investment into research to identify sex-specific differences in cancer therapies. It is well known that women experience greater changes and fluctuations in hormone levels, which are affected by factors such as age, contraception and menopause. Hormones can significantly affect the immune system and the body’s ability to metabolise drugs. Therefore, sex-related dosing, or dosing that is synchronised with hormone cycles is needed. Liver function also plays an important role, as this differs between men and women. More research could close the gap in this field.”

 

To support the “closing the gap” campaign, touchONCOLOGY is helping to raise awareness of this important topic. View some of our recent content to learn more about cancer care and the use of digital innovations in the field of oncology.

Want to find out more?

Everett E Vokes (President, American Society of Clinical Oncology) discusses the greatest challenges for the worldwide oncology community.

Andreas Charalambous (President Elect, European Cancer Organisation) highlights the main challenges to cancer care within Europe.

Domenico D’Ugo (President, European Society of Surgical Oncology) talks about how the latest innovations in artificial intelligence are helping to improve cancer care.

 

Please don’t hesitate to get in touch and visit our touchONCOLOGY site here for more videos and news content

Share this Article
Related Content In touchIME
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72